These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies. Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591 [TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM). Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039 [TBL] [Abstract][Full Text] [Related]
6. [Islet autoantibody assays in type I diabetes: superiority of passage from use of ICA to traditional tests]. Lazar D; Weintrob N; Abramov N; Assa S; Bloch K; Ofan R; Ben-Zaken H; Vardi P Harefuah; 1998 May; 134(9):678-81, 750. PubMed ID: 10909610 [TBL] [Abstract][Full Text] [Related]
7. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM? Schmidli RS; Colman PG; Harrison LC J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043 [TBL] [Abstract][Full Text] [Related]
8. High prevalence of antibodies to glutamic acid decarboxylase in comparison to islet cell antibodies in patients with long-standing insulin-dependent diabetes mellitus. Imagawa A; Itoh N; Hanafusa T; Katsura H; Yamaguchi A; Takeda A; Iwahashi H; Nakajima H; Miyagawa J; Namba M; Kuwajima M; Matsuzawa Y Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):43-52. PubMed ID: 8733827 [TBL] [Abstract][Full Text] [Related]
9. The detection of autoantibodies to pancreatic islet cells by immunoenzyme histochemistry. Kohnert KD; Rjasanowski I; Hehmke B; Hamann J; Keilacker H; Michaelis D Diabetes Res; 1994; 25(1):1-12. PubMed ID: 7648777 [TBL] [Abstract][Full Text] [Related]
10. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086 [TBL] [Abstract][Full Text] [Related]
11. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies. Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186 [TBL] [Abstract][Full Text] [Related]
12. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes. Williams AJ; Bingley PJ; Moore WP; Gale EA; Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153 [TBL] [Abstract][Full Text] [Related]
13. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. Velloso LA; Kämpe O; Hallberg A; Christmanson L; Betsholtz C; Karlsson FA J Clin Invest; 1993 May; 91(5):2084-90. PubMed ID: 8486775 [TBL] [Abstract][Full Text] [Related]
14. [Detection of antibodies against pancreatic islet cells in clinical practice]. Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715 [TBL] [Abstract][Full Text] [Related]
15. Multiple antibody status in type 1 diabetic patients and subjects at various risk with islet-cell antibodies. Maugendre D; Chaillous L; Rohmer V; Lecomte P; Marechaud R; Saï P; Marre M; Charbonnel B; Allannic H; Delamaire M Diabetes Metab; 1997 Sep; 23(4):320-6. PubMed ID: 9342546 [TBL] [Abstract][Full Text] [Related]
16. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus. Walikonis JE; Lennon VA Mayo Clin Proc; 1998 Dec; 73(12):1161-6. PubMed ID: 9868413 [TBL] [Abstract][Full Text] [Related]
18. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group. Ongagna JC; Levy-Marchal C Diabetes Metab; 1997 Apr; 23(2):155-60. PubMed ID: 9137905 [TBL] [Abstract][Full Text] [Related]
19. [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies]. Yang L; Zhou ZG; Huang G; Yan X Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):309-14. PubMed ID: 16136967 [TBL] [Abstract][Full Text] [Related]
20. Comparison of a new anti-glutamic acid decarboxylase (GAD) enzyme-linked immunosorbent assay (ELISA) with radioimmunoassay methods: a multicenter study. Wild T; Scherbaum WA; Gleichmann H; Landt M; Santiago J; Endl J; Landgraf R; Cavallo MG; Ganz M; Pozzilli P Horm Metab Res; 1997 Aug; 29(8):403-6. PubMed ID: 9288579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]